Accelerate Diagnostics Schedules Call to Review Second Quarter 2017 Results for August 3rd
18 juil. 2017 17h38 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., July 18, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Thursday, August 3, 2017 to discuss its second quarter 2017 financial...
Accelerate Diagnostics to Present at the 37th Annual Growth Stock Conference hosted by William Blair & Company
07 juin 2017 18h06 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., June 07, 2017 (GLOBE NEWSWIRE) -- Lawrence Mehren, president and chief executive officer of Accelerate Diagnostics, will present at the 37th Annual Growth Stock Conference hosted by...
Accelerate Diagnostics Announces Closing of $79.3 Million Upsized Offering
15 mai 2017 17h14 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., May 15, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced the closing of its previously announced underwritten public offering of 2,750,000 shares of its...
Accelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017
03 mai 2017 16h05 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., May 03, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary financial results for the quarter ending March 31, 2017 including signed customer evaluation...
Accelerate Diagnostics Schedules Call to Review First Quarter 2017 Results for May 3rd
18 avr. 2017 17h53 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., April 18, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Wednesday, May 3rd, 2017 to discuss its first quarter 2017 financial...
Accelerate Diagnostics Receives FDA Marketing Authorization for the Accelerate Pheno™ System and Accelerate PhenoTest™ BC Kit
23 févr. 2017 21h45 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Accelerate) today announced that the U.S. Food and Drug Administration has granted the de novo request to market the...
Great Basin Scientific Participates in CDC’s Get Smart About Antibiotics Week, Releases Antimicrobial Stewardship Survey Findings
17 nov. 2016 09h00 HE
|
Great Basin Scientific, Inc.
Survey finds hospitals moving toward antimicrobial stewardship programs; Company’s Staph ID/R Blood Culture Panel provides fast and affordable diagnostic tool in fight against antibiotic...
Great Basin Scientific Completes Clinical Trial for Stool Bacterial Pathogens Panel
08 nov. 2016 07h00 HE
|
Great Basin Scientific, Inc.
SALT LAKE CITY, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, announced today the successful completion of the clinical trial of its...
Accelerate Diagnostics to Report Third-Quarter 2016 Results on November 9th
21 oct. 2016 17h45 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Oct. 21, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will report third-quarter 2016 financial results on Wednesday, November 9, 2016. President and...